À propos de GlycoNet
Comité des Finances et de Vérification
Comité des Nominations
Comité de Gestion de la Recherche
Conseil Scientifique (CS)
Comité de Commercialisation et du Legs
Comité pour l’Équité, la Diversité et l’Inclusion
Comité de Formation
Le Comité Exécutif prend des décisions urgentes entre les réunions du Conseil. Les décisions sont ratifiées lors de la prochaine réunion du Conseil.
A highly-recognized Canadian life sciences leader, Karimah brought 30 years of dynamic global business experience to her role as CEO and Partner at Quark Venture. She previously held the position of CEO at CDRD, where she was responsible for ensuring the organization’s long-term sustainability, while leading its business functions and successfully building the many national and international alliances and strategic partnerships which are now contributing significantly to advancing the goals of CDRD.
Joseph is a partner who practises in the areas of corporate finance and mergers & acquisitions at Blake, Cassels & Graydon LLP. Joseph advises high growth public and private companies, underwriters, pension funds, private equity groups, and venture capital investors on complex domestic and cross-border private and public securities offerings, mergers & acquisitions, and international commercial transactions. He advises clients in a variety of industries, including life sciences, technology, retail, mining and clean technology.
Nils is a Fellow of the Chemical Institute of Canada. He currently serves as a member of three boards of not-for-profit organizations including Compute Canada, TECTERRA, and the Canadian Light Source (CLS) for which he is Chair of the Board. He recently finished terms as a member of the boards of ArboraNano, a Business-led NCE, the California Nanosystems Institute (CNSI), and the Pacific Institute for Mathematical Sciences, and as Chair of the Board of NSERC’s Strategic Network program BiopSys at the University of Toronto.
Stewart is a successful Edmonton businessman with broad experience in the chemical industry. He is the past Chair of the Alberta Hospital Edmonton Foundation, Director of Northeast Capital Industrial Association (NCIA), Chair of NCIA Education Committee, and a member of Synergy Networks in Edmonton.
Warren is a Professor from the Department of Biological Sciences at the University of Alberta. The Wakarchuk lab investigates the structure and function of the enzymes which make and degrade various glycoconjugates. This work has been enabling the chemo-enzymatic synthesis of bioactive glycoconjugates both in the laboratory and for industrial projects. The Wakarchuk lab has expertise with both mammalian and bacterial carbohydrate active enzymes for glycan remodelling applications.
Elizabeth is the CEO of GlycoNet. She was involved in the GlycoNet initiative since the Letter of Intent stage and served as the Associate Director, Business for the Alberta Glycomics Centre from 2007–2015. Prior to her position with the Centre, she worked as a manager of large-scale and multi-institutional projects with Genome Prairie. In addition to her PhD in biochemistry, Elizabeth has an MBA in biotechnology management.
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.